ECT has been found effective in mitigating the deleterious consequences of SIB.
It’s an FDA approved technology, but what exactly is TMS and why should you be aware of it?
For ethical and economic reasons, when patients are acutely ill with catatonia and melancholia, ECT is best considered sooner rather than later.
The author interviews Jonathan Sadowsky, PhD, historian of psychiatry, about his book Electroconvulsive Therapy in America: The Anatomy of a Medical Controversy.
The latest news in geriatric psychiatry covers olfactory deficits in cognitively impaired patients, a smartphone app for older adults with serious mental illness, and adjunctive ketamine for late-life depression.
Among patients with treatment-resistant MDD, transcranial magnetic stimulation wins the popular vote.
ECT has been an acute intervention for patients with severe resistant MDD, but what is its effect on brain volume?
The guidelines and research discussed in this slideshow assess the benefits of various therapies for depressive disorders.
The author scrutinizes the results of a new pilot study that finds the Fisher Wallace Stimulator® effective in treating bipolar depression.
Simply telling patients “we don’t know how ECT works” neglects our abundant knowledge of what this treatment does. The authors review biological actions of ECT and discuss future directions for research.